BURLINGTON, N.C., Jan. 15, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth ...
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident ...
Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer MRD testing helps clinicians track a patient's risk ...
Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...
Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...
Oct 28 (Reuters) - Laboratory services provider Labcorp (LH.N), opens new tab forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to ...
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...
When complete, the transaction is expected to provide patients, physicians and customers with greater access to Labcorp's comprehensive, high-quality laboratory services, scientific expertise and ...
Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive ...
BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has ...
Jefferies assumed coverage of Labcorp (LH) with a Buy rating with a price target of $275, up from $265. Larger full-service reference labs, such as Labcorp, stand to benefit from the same tailwinds as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results